Form: 3/A

Initial statement of beneficial ownership of securities

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Sofinnova HealthQuest Partners, L.P.
(Last) (First) (Middle)
C/O HEALTHQUEST, 1301 SHOREWAY RD
SUITE 350
(Street)
BELMONT CA 94002
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/24/2019 		3. Issuer Name and Ticker or Trading Symbol
CASTLE BIOSCIENCES INC [ CSTL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
07/24/2019
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock (1) (1) Common Stock 16,015 (1) D(3)
Series E-2 Preferred Stock (1) (1) Common Stock 358,416 (1) D(3)
Series E-3 Preferred Stock (1) (1) Common Stock 318,842 (1) D(3)
Series F Preferred Stock (1) (1) Common Stock 982,785 (1) D(3)
Series F Preferred Stock Warrant (right to buy) 01/12/2018 01/12/2023 Common Stock 11,572 0.01 D(3)
Convertible Promissory Note (2) (2) Common Stock $1,027,882 (2) D(3)
1. Name and Address of Reporting Person*
Sofinnova HealthQuest Partners, L.P.
(Last) (First) (Middle)
C/O HEALTHQUEST, 1301 SHOREWAY RD
SUITE 350
(Street)
BELMONT CA 94002
(City) (State) (Zip)
1. Name and Address of Reporting Person*
HealthQuest Venture Management, L.L.C.
(Last) (First) (Middle)
C/O HEALTHQUEST, 1301 SHOREWAY RD
SUITE 350
(Street)
BELMONT CA 94002
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Kong Garheng
(Last) (First) (Middle)
C/O HEALTHQUEST, 1301 SHOREWAY RD
SUITE 350
(Street)
BELMONT CA 94002
(City) (State) (Zip)
Explanation of Responses:
1. All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration at a rate of one share of Common Stock for each 1.219 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
2. The principal amount of the Convertible Promissory Note held by the designated Reporting Person is $1,027,882. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the "Conversion Amount") will automatically convert into the number of shares of Common Stock that is equal to the Conversion Amount as of the closing date divided by 80% of the IPO price per share.
3. The shares are directly held by Sofinnova HealthQuest Partners, L.P. ("HealthQuest"). HealthQuest Venture Management, L.L.C. ("HQVM"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.
Remarks:
This is an amendment to the Form 3 filed on July 24, 2019, which did not include HealthQuest Venture Management, L.L.C., the general partner of Sofinnova HealthQuest Partners, L.P., as a reporting person on such Form 3. This amendment restates the same substantive information included in the previously filed Form 3 and contains HealthQuest Venture Management, L.L.C. as a reporting person.
/s/ Garheng Kong as Managing Member of HealthQuest Venture Management, L.L.C., general partner of Sofinnova HealthQuest Partners, L.P. 07/26/2019
/s/ Garheng Kong as Managing Member of HealthQuest Venture Management, L.L.C. 07/26/2019
/s/ Garheng Kong 07/26/2019
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.